TATE & LYLE RECEIVES INNOVATION IN HEALTH TECHNOLOGY PRODUCT AWARD

Tate & Lyle’s Jessie Han, Sales Director, Greater China, accepts the award

Shanghai, China – 25 June 2026 – Tate & Lyle PLC (Tate & Lyle), a global leader in ingredient solutions for healthier food and beverages, is delighted to announce that it has received the Innovation in Health Technology Product Award at the Boao Food for Health Science Conference and Expo (FHE) 2026, recognising its leadership in precision prebiotic technologies and evidence-based nutritional research. 

The award celebrates innovations that demonstrate meaningful scientific advancement, strong validation, and the ability to deliver measurable health benefits in real-world food and beverage applications. 

At the event in Boao, Hainan, China, Tate & Lyle showcased its portfolio of functional oligosaccharide dietary fibres and prebiotic solutions. This includes EUOLIGO® FOS, GOSYAN® GOS, PROMITOR® Soluble Fibre and STA-LITE® Polydextrose – forming a comprehensive and scalable fibre portfolio designed to support gut health and enable product innovation across a wide range of food and beverage applications. 

The breadth and value of Tate & Lyle’s comprehensive fibre portfolio is underpinned by an integrated research framework and application expertise, enabling customers to translate scientific insight into commercially viable products. Together, these capabilities support the development of solutions that are grounded in robust science and designed to perform in real-world conditions. 

Commenting on the award, Remington Zhu, President, Asia Pacific at Tate & Lyle, said: “This award recognises our scientific capabilities and our continued focus on advancing prebiotic innovation. Our approach is centred on translating scientific research into practical solutions that support health while meeting the expectations of both customers and consumers. 

“As demand for functional ingredients continues to grow, we remain focused on delivering solutions that are scientifically robust, scalable, and designed to work across a wide range of applications.” 

This recognition reflects Tate & Lyle’s research capabilities and reinforces its role in advancing science-led innovation across the food and health industry. 

More Articles from the Medical Industry

TATE & LYLE RECEIVES INNOVATION IN HEALTH TECHNOLOGY PRODUCT AWARD

Tate & Lyle’s Jessie Han, Sales Director, Greater China, accepts the award Shanghai, China – 25 June 2026 – Tate …

Inaugural Smart Health Asia Opens in Singapore: 80 sessions with more than 140 senior speakers from 18 countries

From left to right: Ms. Ong Huey Hong (Assistant Chief Executive (Industry Development Group), Singapore Tourism Board), Mr. Alvin Tan …

Agilent and Singapore’s NATi Partner to Advance Lipid Conjugated Oligonucleotide Research  

Collaboration expands research of new delivery platform beyond liver tissues supporting potential preclinical development and strengthens Singapore’s position as a …

REHACARE CHINA Forges Strategic Partnership with National Development and Supply Center of Assistive Products —— A Powerful Alliance Connecting Global Markets

Messe Düsseldorf (Shanghai) Co., Ltd., the organizer of REHACARE CHINA, enters into a strategic partnership with the National Development and …
Share via
Copy link